Metabolic and Bariatric Surgery · 30 November 2025

Roux-en-Y Bypass Outperforming Sleeve Gastrectomy for Diabetes Remission

Roux-en-Y gastric bypass offers better outcomes for type 2 diabetes remission than sleeve gastrectomy in obese patients.

Patients receiving Roux-en-Y showed higher remission rates for diabetes at 1 and 3 years, with significant differences from sleeve gastrectomy.
At 1 and 3 years, HbA1c levels were lower in the Roux-en-Y group, indicating better glycemic control.

Prioritize Roux-en-Y for patients needing effective diabetes management along with weight loss.

Roux-en-Y also led to greater reductions in total cholesterol and LDL levels compared to sleeve gastrectomy.

Journal Article by Cheng Y, Xie Y (…) Yuan J et 7 al. in Int J Surg

read the whole article in Int J Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

Ann Surg13 Jul 2026

Predictive Models Enhance Diabetes Remission After Surgery

A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.

Ann Surg16 Jun 2026

EndoBarrier Shows Promise for Type 2 Diabetes in Obesity

Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.

All papers in Metabolic and Bariatric Surgery →